Posts Tagged ‘ICPH’
IBA to Install Proton Therapy Facility at the Inova Schar Cancer Institute in Virginia, USA
Contract signed with Inova for two-room Proteus®PLUS* proton therapy system near IBA’s North American Headquarters Reston, VA, USA, July 5th, 2017 – IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions for the treatment of cancer, and Inova, a global leader in personalized health, today signed a contract for a two-room…
Read MoreInova Translational Medicine Institute Deploys Cloudera Bio-IT World
Inova Translational Medicine Institute today announced that it has deployed Cloudera Enterprise to securely analyze massive collections of clinical and genomic data at unprecedented speeds and scale for faster innovations in translational medicine research. Read more.
Read MoreInova: Uncovering Breakthrough Insights that Help Save Lives Cloudera
With Cloudera Enterprise, Inova researchers can answer questions magnitudes faster than they could previously to help the organization realize its goal of delivering precision medicine. Watch more.
Read MoreInova Aims to Offer Unique Home for Startups Through Its Personalized Health Accelerator, GenomeWeb.com
Inova Health System, a multi-hospital system in the Washington, D.C., area, is getting ready to open one of the more unique startup accelerators in healthcare: one dedicated to personalized medicine. Read more.
Read MoreTwo Va. research powerhouses come together on projects with seed fund, Washington Business Journal
Inova Health System and University of Virginia are kicking off their new partnership with $450,000 in seed money to fund nine joint research projects geared toward better predicting, preventing and treating disease. Read more.
Read MoreUVA, Inova award research seed funding grants to joint research teams
The Inova Health System (Inova) and the University of Virginia (UVA) announced today that they have awarded $450,000 to nine UVA-Inova joint research teams for projects focused on how to better predict, prevent and treat disease. In the fall of 2016, Inova and UVA announced a comprehensive research and education partnership to accelerate joint discovery…
Read MoreBRCA Testing Gets a Lot of Attention. Is It Right For You?
Amanda Schott, MS, is a clinical cancer genetic counselor at the Inova Translational Medicine Institute (ITMI). Read Amanda Schott’s profile. The Washington Post recently published a profile of Alejandra Campoverdi, a former White House staffer who decided to run for Congress in her native Los Angeles. While she didn’t win that nomination, Campoverdi is making…
Read MoreShenandoah University and Inova Partner to Educate the Healthcare Workforce of the Future
Inova Center For Personalized Health To House Programs Winchester, Va. (April 3, 2017) – Shenandoah University and Inova announced today a collaborative partnership to educate the next generation of healthcare professionals with an emphasis on population health, pharmacogenomics, and other new healthcare technologies. The partnership builds upon the individual strengths of Inova and Shenandoah and…
Read MoreInova and the FNIH Biomarkers Consortium Launch Public-Private Partnership to Develop Novel Imaging Methods to More Accurately Measure Cancer Response and Progression
FALLS CHURCH, VA – Inova, in coordination with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, is launching a three-year research partnership to develop new methods for analyzing digital images that track a patient’s response to cancer therapy. Michael Maitland, MD, PhD, Director of Therapeutics for the Inova Center for Personalized Health…
Read MoreInova Schar Cancer Institute Oncologist Jeanny Aragon-Ching Selected for ASCO Leadership Development Program
FALLS CHURCH, VA – Inova is pleased to announce that Jeanny Aragon-Ching, MD, has been selected to participate in the esteemed American Society of Clinical Oncology (ASCO) Leadership Development Program for years 2017-2018. The ASCO Leadership Development Program is a year-long course for a mid-career group of highly accomplished practicing oncologists. It positions them to…
Read More